The information highlighted (if any) are the most recent updates for this brand.
KERENDIA is indicated to delay progressive decline of kidney function in adults with chronic kidney disease associated with Type 2 diabetes (with albuminuria), in addition to standard of care (see Pharmacology: Pharmacodynamics: Clinical Trials under Actions).